NIV for obesity hypoventilation syndrome
The main goals of treatment for OHS patients are as follows:
- Normalise arterial carbon dioxide tension (PaCO2 45 mm Hg)
- Prevent hypoxemia during sleep and wakefulness
- Prevent erythrocytosis, pulmonary hypertension, and respiratory failure
- Relieve hypersomnia and altered mentation
Treatment with NIV helps to achieve these goals, and has been widely observed to be the ideal treatment for OHS. 1
The following Resmed devices are used to treat obesity hypoventilation syndrome:
- S9 VPAP™ ST-A
- Stellar™ 150
- Lumis™ series
Reference
1
Borel JC, et al. Obesity hypoventilation syndrome: from sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies. Respirology. 2012 May;17(4):601-10